Metraipolis › archive › dc_8e8b6026d7e2

Efficacy and safety of tislelizumab in patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis — Europe PMC PMID:40850957

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40850957
DOI
10.1186/s43046-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-10T09:35:21.916Z
SHA-256 of the archived text
73a0c47a83c1332a0a93abfdb0af3918bfd33ca011e3ebf7a5da306bdae854ea
Stable URL of this page
https://metraipolis.com/documento/dc_8e8b6026d7e2

How to cite

Efficacy and safety of tislelizumab in patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis — Europe PMC PMID:40850957 — Europe PMC (en), https://europepmc.org/article/MED/40850957 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8e8b6026d7e2 (Metraipolis archive dc_8e8b6026d7e2, sha256 73a0c47a83c1332a0a93abfdb0af3918bfd33ca011e3ebf7a5da306bdae854ea)
BibTeX
@misc{dc8e8b6026d7e2,
  title = {Efficacy and safety of tislelizumab in patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis — Europe PMC PMID:40850957},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40850957},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8e8b6026d7e2; sha256 73a0c47a83c1332a0a93abfdb0af3918bfd33ca011e3ebf7a5da306bdae854ea},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40850957. Agents can read the archived copy with the MCP tool read_document.